Gil-Vernet S - Search Results

1

Face transplant: long-term follow-up and results of a prospective open study.

Lantieri L, Grimbert P, Ortonne N, Suberbielle C, Bories D, Gil-Vernet S, Lemogne C, Bellivier F, Lefaucheur JP, Schaffer N, Martin F, Meningaud JP, Wolkenstein P, Hivelin M. Lantieri L, et al. Lancet. 2016 Oct 1;388(10052):1398-1407. doi: 10.1016/S0140-6736(16)31138-2. Epub 2016 Aug 25. Lancet. 2016. PMID: 27567680

2

Antilymphocyte globulin versus OKT3 induction therapy in cadaveric kidney transplantation: a prospective randomized study.

Grino JM, Castelao AM, Serón D, Gonzalez C, Galceran JM, Gil-Vernet S, Andrés E, Mestre M, Torras J, Alsina J. Grino JM, et al. Am J Kidney Dis. 1992 Dec;20(6):603-10. doi: 10.1016/s0272-6386(12)70227-5. Am J Kidney Dis. 1992. PMID: 1462990 Clinical Trial.

3

Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.

Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM. Koga A, et al. Transplant Proc. 2004 Jun;36(5):1305-7. doi: 10.1016/j.transproceed.2004.05.064. Transplant Proc. 2004. PMID: 15251318 Clinical Trial.

4

Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: long-term results.

Rama I, Cruzado JM, Gil-Vernet S, Torras J, Serón D, Castelao AM, Ibernón M, Bestard O, Grinyó JM. Rama I, et al. Transplantation. 2005 Jul 27;80(2):164-8. doi: 10.1097/01.tp.0000165109.06382.56. Transplantation. 2005. PMID: 16041259

5

Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival.

Bestard O, Cruzado JM, Torras J, Gil-Vernet S, Serón D, Moreso F, Rama I, Grinyó JM. Bestard O, et al. Transplant Proc. 2005 Nov;37(9):3774-7. doi: 10.1016/j.transproceed.2005.09.170. Transplant Proc. 2005. PMID: 16386535

6

Pathological differential diagnostics of proteinuria and late failure after renal transplantation.

Castelao AM, Griñó JM, Serón D, Andrés E, GilVernet S, Bover J, Carrera M, Torras J, Alsina J. Castelao AM, et al. Transplant Proc. 1992 Feb;24(1):110-2. Transplant Proc. 1992. PMID: 1539198 No abstract available.

7

Combined liver-kidney transplantation.

Gil-Vernet S, Prieto C, Griñó JM, Leiva O, Castelao AM, Algranati L, Figueras J, Jaurrieta E, Moreno E, Serrallach N. Gil-Vernet S, et al. Transplant Proc. 1992 Feb;24(1):128-9. Transplant Proc. 1992. PMID: 1539207 No abstract available.

8

Clinical results of quadruple drug immunosuppression in liver transplantation.

Fabregat J, Fradera R, Jaurrieta E, Figueras J, Rafecas A, Rufi G, Casanovas T, Casais L, Gil Vernet S. Fabregat J, et al. Transplant Proc. 1992 Feb;24(1):148-9. Transplant Proc. 1992. PMID: 1539217 No abstract available.

9

Disseminated intravascular coagulation in multiorgan donors.

Gil-Vernet S, Martinez-Brotons F, Gonzalez C, Domenech P, Carreras M. Gil-Vernet S, et al. Transplant Proc. 1992 Feb;24(1):33. Transplant Proc. 1992. PMID: 1539297 No abstract available.

10

Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.

Griñó JM, Castelao AM, Serón D, Gonzalez C, Galceran JM, Gil-Vernet S, Andrés E, Bover J, Torras J, Alsina J. Griñó JM, et al. Transplant Proc. 1992 Feb;24(1):39-41. Transplant Proc. 1992. PMID: 1539329 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page